TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

KV Pharmaceuticals Case 04/08/2008

  • If you purchased a significant amount of shares of this company you have certain options and for certain investors are short and strict deadlines running. Investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

Company
KV Pharmaceutical Co.
Security

Case Name
KV Pharmaceuticals Case 04/08/2208
Type of Lawsuit
Stockholder Derivative Action
You must register or login to receive notifications.

Click here to subscribe to KV Pharmaceutical Co..
Summary

<p>St. Louis-based KV Pharmaceuticals Inc. said on Monday that a settlement was reached. in the shareholders derivative lawsuit. The shareholders derivative lawsuit was filed over KV Pharmaceuticals Inc.’s directors options granting practices. KV Pharmaceuticals Inc. did not disclose the amount of the settlement, but said it expected insurance to cover the fees and costs, and will be able to put soon its stock options backdating litigation behind it.</p>